home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Arcus Biosciences, Inc. Common Stock (NY:RCUS)

24.13 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, May 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arcus Biosciences, Inc. Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Arcus Biosciences Reports Second-Quarter 2023 Financial Results and Provides a Pipeline Update

August 07, 2023

From Arcus Biosciences

Via Business Wire

Preview: Arcus Biosciences's Earnings ↗

August 04, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 31, 2023

Via Benzinga

Arcus Biosciences Announces New Employment Inducement Grants

July 25, 2023

From Arcus Biosciences

Via Business Wire

Citigroup Maintains Buy Rating for Arcus Biosciences: Here's What You Need To Know ↗

May 26, 2023

Via Benzinga

MarketBeat Week in Review – 7/10 - 7/14

July 15, 2023

As inflation moderates, Investors are optimistic for the second quarter earnings season and that optimism is evident in some of the top stories from this week

Via MarketBeat

Topics Economy

Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus

July 13, 2023

Regulatory filings show Gilead Sciences' purchase of shares in AlloVir and Arcus. Strategic investments in the biotech sector are fairly common to boost growth.

Via MarketBeat

Topics Retirement

3 Biotech Stocks to Buy for Long-Term Gains

July 13, 2023

The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors.

Via MarketBeat

Topics ETFs Economy

Arcus Biosciences Announces New Employment Inducement Grants

July 11, 2023

From Arcus Biosciences

Via Business Wire

Over $59M Bet On This Communication Services Stock? Check Out These 3 Stocks Insiders Are Buying ↗

July 03, 2023

Although US stocks closed higher on Friday, there were a few notable insider trades.

Via Benzinga

BJ's Wholesale Club, Verint Systems And 2 Other Stocks Insiders Are Selling ↗

June 27, 2023

The S&P 500 closed lower on Monday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Arcus Biosciences Announces New Employment Inducement Grants

June 26, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

June 09, 2023

From Arcus Biosciences

Via Business Wire

Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review ↗

June 09, 2023

The Nasdaq held near 52-week highs while small caps ramped up.

Via Investor's Business Daily

ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes ↗

June 05, 2023

ImmunoGen and Day One gained Monday on their updates at a cancer treatment conference.

Via Investor's Business Daily

Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study

June 03, 2023

From Gilead Sciences, Inc.

Via Business Wire

3 Undervalued Biotech Stocks to Buy Before They Blast Off ↗

June 02, 2023

Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.

Via InvestorPlace

Arcus Biosciences to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

May 30, 2023

From Arcus Biosciences

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 29, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 26, 2023

Via Benzinga

Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday ↗

May 26, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 26, 2023

Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.

Via Benzinga

Arcus Biosciences Soars On Roche's 'Meaningful' Results In A New Cancer Drug Class ↗

May 26, 2023

Roche tested its treatment in patients with liver cancer and found "meaningful" results.

Via Investor's Business Daily

Nasdaq Rises 1%; US Goods Trade Gap Widens In April ↗

May 26, 2023

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 1% on Friday. Following the market opening Friday, the Dow traded up 0.87% to 33,050.97 while the NASDAQ rose 1.06% to...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 26, 2023

Via Benzinga

Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

May 26, 2023

Gainers Oncorus, Inc. (NASDAQ: ONCR) shares rose 90% to $0.38 in pre-market trading after dropping around 17% on Thursday. Oncorus recently posted a narrower-than-expected quarterly loss.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 26, 2023

It's time for another dive into the biggest pre-market stock movers as we check out what's happening this morning on Friday!

Via InvestorPlace

Arcus Biosciences Announces New Employment Inducement Grants

May 24, 2023

From Arcus Biosciences

Via Business Wire

3 Analyst Upgrades That Smart Investors Won’t Ignore ↗

May 17, 2023

In many cases, analyst upgrades can point investors to opportunities like the ones in the stocks on this list.

Via InvestorPlace

Presentations at the 2023 ASCO Annual Meeting Highlight Arcus Biosciences’ Expanding Portfolio of Investigational Medicines and Late-Stage Studies Across Multiple Types of Cancer

May 17, 2023

From Arcus Biosciences

Via Business Wire

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com